, Tracking Stock Market Picks
Enter Symbol:
Markel Corporation (MKL) [hlAlert]

Mkt Perform
down 23.29 %

Markel Corporation (MKL) upgraded to Mkt Perform by Keefe Bruyette

Posted on: Monday,  Aug 20, 2012  8:25 AM ET by Keefe Bruyette

Keefe Bruyette rated Mkt Perform Markel Corporation (NYSE: MKL) on 08/20/2012. Previously Keefe Bruyette rated Underperform Markel Corporation (NYSE: MKL) on
12/14/2009., when the stock price was $336.91. Since then, Markel Corporation has gained 30.36% as of 08/20/2012's recent price of $439.20.
If you would have followed the previous Keefe Bruyette's recommendation on MKL, you would have lost 23.29% of your investment in 980 days.

Markel Corporation markets and underwrites specialty insurance products and programs to a range of markets. The Company has three segments of the specialty insurance marketplace: the Excess and Surplus Lines (E and S), the Specialty Admitted and the London markets. The E and S market focuses on hard-to-place risks and loss exposures that generally cannot be written in the standard market. E and S eligibility allows its insurance subsidiaries to underwrite loss exposures with policy forms and unregulated premium rates. The Company also writes business in the Specialty Admitted market. In addition, the Company writes business on both a direct and subscription basis in the London market.

KBW produces industry-leading research on more financial services companies than any other brokerage firm. Our Research Group follows the majority of the financial services companies in the S&P 500 and Dow Jones STOXX 600 Index, as well as hundreds of other U.S. and European financial services companies on a daily basis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/20/2012 8:25 AM Hold
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD down  -5.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/14/2009 9:25 AM Sell
336.91 330.00
10/30/2008 8:25 AM Hold
343.70 360.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy